Skip to Content
Merck
CN
  • Parvovirus B19-Infected Tubulointerstitial Nephritis in Hereditary Spherocytosis.

Parvovirus B19-Infected Tubulointerstitial Nephritis in Hereditary Spherocytosis.

Open forum infectious diseases (2020-08-08)
Kei Nishiyama, Yuka Watanabe, Masataka Ishimura, Kenichi Tetsuhara, Takashi Imai, Hikaru Kanemasa, Kenji Ueki, Yoshitomo Motomura, Noriyuki Kaku, Yasunari Sakai, Ken-Ichi Imadome, Shouichi Ohga
ABSTRACT

Human parvovirus B19 (B19V) causes glomerulopathy or microangiopathy, but not tubulopathy. We experienced an 11-year-old girl with spherocytosis who developed acute kidney injury on a primary infection of B19V. She presented with anuria, encephalopathy, thrombocytopenia, and coagulopathy, along with no apparent aplastic crisis. Continuous hemodiafiltration, immunoglobulin, and intensive therapies led to a cure. A kidney biopsy resulted in a histopathological diagnosis of tubulointerstitial nephritis without immune deposits. The virus capsid protein was limitedly expressed in the tubular epithelial cells with infiltrating CD8-positive cells. Viral and histopathological analyses first demonstrated B19-infected tubulointerstitial nephritis due to the aberrant viremia with hereditary spherocytosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Fluorescein (free acid), Dye content 95 %
Sigma-Aldrich
Anti-Parvovirus B19 Antibody, aa 328-344 of VP2 capsid protein, clone R92F6, clone R92F6, Chemicon®, from mouse